Gainers
- Precipio PRPO stock increased by 31.0% to $7.99 during Thursday's pre-market session. The market value of their outstanding shares is at $11.8 million.
- Seres Therapeutics MCRB stock moved upwards by 24.35% to $0.97. The market value of their outstanding shares is at $165.6 million.
- Traws Pharma TRAW stock increased by 23.85% to $8.49. The company's market cap stands at $25.6 million.
- Aclarion ACON shares increased by 17.41% to $0.05.
- Hepion Pharmaceuticals HEPA stock moved upwards by 14.56% to $0.49. The company's market cap stands at $3.4 million.
- Citius Pharmaceuticals CTXR shares increased by 12.94% to $3.84. The company's market cap stands at $32.5 million.
Losers
- MSP Recovery MSPR shares declined by 16.5% to $1.92 during Thursday's pre-market session. The company's market cap stands at $4.0 million.
- Artiva Biotherapeutics ARTV stock declined by 15.59% to $6.01. The company's market cap stands at $145.9 million.
- Silexion Therapeutics SLXN stock decreased by 15.39% to $1.32. The company's market cap stands at $2.1 million.
- GlucoTrack GCTK stock fell 14.94% to $0.07. The market value of their outstanding shares is at $1.0 million.
- Autonomix Medical AMIX stock fell 11.85% to $2.68. The market value of their outstanding shares is at $4.7 million.
- Eterna Therapeutics ERNA shares declined by 10.93% to $0.39. The company's market cap stands at $19.9 million. See Also: www.benzinga.com/money/best-healthcare-stocks/
This article was generated by Benzinga's automated content engine and reviewed by an editor.
AMIXAutonomix Medical Inc
$2.70-11.2%
ARTVArtiva Biotherapeutics Inc
$6.00-15.7%
CTXRCitius Pharmaceuticals Inc
$3.8412.9%
ERNAEterna Therapeutics Inc
$0.3755-13.8%
GCTKGlucoTrack Inc
$0.0638-19.2%
HEPAHepion Pharmaceuticals Inc
$0.45205.68%
MCRBSeres Therapeutics Inc
$0.7610-2.44%
MSPRMSP Recovery Inc
$1.92-16.5%
PRPOPrecipio Inc
$8.0031.1%
SLXNSilexion Therapeutics Corp
$1.29-17.3%
TRAWTraws Pharma Inc
$8.4923.9%
© 2025 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Benzinga simplifies the market for smarter investing
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.
Join Now: Free!
Already a member?Sign in